Kyle Jones

City:

La Jolla, California

Country:

United States

Published Applications:

Last publication date:

2026-05-14

Top Assignees for applications by Kyle Jones

The entities that hold a legal rights for patent applications filed by inventor Jones Kyle:

Inhibrx, Inc. 3 La Jolla, CA United States
Inhibrx Biosciences, Inc. 2 La Jolla, CA United States
2seventy bio, Inc. 2 Cambridge, MA United States
InhibRx LLC 2 La Jolla, CA United States
Regeneron Pharmaceuticals, Inc. 2 Tarrytown, NY United States
Inhibex, Inc. 1 La Jolla, CA United States

Recent patent applications by Jones Kyle

Kyle Jones from La Jolla, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-14

US20260132184A1

Chemistry; metallurgy

CD33 TARGETED IMMUNOTHERAPIES

#2 | 2024-05-23

US20240166744A1

Chemistry; metallurgy

NON-PLATELET DEPLETING AND NON-RED BLOOD CELL DEPLETING CD47 ANTIBODIES AND METHODS OF USE THEREOF

#3 | 2022-10-13

US20220324942A1

Chemistry; metallurgy

CD33 TARGETED IMMUNOTHERAPIES

#4 | 2022-10-06

US20220315638A1

Chemistry; metallurgy

CD123 TARGETED IMMUNOTHERAPIES

#5 | 2021-10-14

US20210317205A1

Chemistry; metallurgy

NON-PLATELET DEPLETING AND NON-RED BLOOD CELL DEPLETING CD47 ANTIBODIES AND METHODS OF USE THEREOF

#6 | 2020-02-20

US20200055946A1

Chemistry; metallurgy

OX40-binding polypeptides and uses thereof

#7 | 2016-09-01

US20160251435A1

Chemistry; metallurgy

NON-PLATELET DEPLETING AND NON-RED BLOOD CELL DEPLETING CD47 ANTIBODIES AND METHODS OF USE THEREOF

#8 | 2014-05-22

US20140140989A1

Chemistry; metallurgy

Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof

#9 | 2013-08-29

US20130224188A1

Chemistry; metallurgy

CD47 antibodies and methods of use thereof

InventorID:

413701 ⎘